James Kihara, Principal Accounting Officer at ACADIA PHARMACEUTICALS INC (ACAD), sold 350 shares at $18.78 ($7K) on 2023-02-24, disclosed to the SEC on 2023-02-27.
Open-market sale of $7k ACAD by Principal Accounting Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ACAD | SELL | 2026-05-05 | $29K | — | Filing → |
| ACAD | SELL | 2026-04-07 | $23K | — | Filing → |
| ACAD | SELL | 2026-03-26 | $42K | — | Filing → |